- 9% growth from last year
- 74% target the disease itself (not just symptoms)
- 182 trials actively recruiting worldwide
Key shift: We're moving BEYOND amyloid to 15 different disease targets.
This is what progress looks like.
Dr. Dominic Ng
- 9% growth from last year
- 74% target the disease itself (not just symptoms)
- 182 trials actively recruiting worldwide
Key shift: We're moving BEYOND amyloid to 15 different disease targets.
This is what progress looks like.
Dr. Dominic Ng
Boom.
Boom.